Article Details
Retrieved on: 2025-01-08 18:02:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Hong Kong-based Insilico Medicine has announced positive results from two Phase I studies of ISM5411 (NCT06012578), a novel gut-restricted and ...
Article found on: www.clinicaltrialsarena.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here